Pharmaceutical News

RSS

BMA calls for urgent meeting with Patricia Hewitt on plans to extend prescribing powers

Mr James Johnson, Chairman of the British Medical Association, has called for an urgent meeting with Patricia Hewitt, Secretary of State for Health, to discuss the government's proposals to extend prescribing powers to nurses and pharmacists.

10 Nov 2005

Waiting for Plan B - don't hold your breath!

According to a Food and Drug Administration official, regulators may take months to review public comments on Barr Pharmaceuticals Inc.'s application to sell the Plan B "morning-after" contraceptive without a prescription.

9 Nov 2005

Refusal to give new breast cancer drug lands health authority in court

British health secretary Patricia Hewitt has become embroiled in a row over the provision of the revolutionary breast cancer drug Herceptin.

9 Nov 2005

Xolair (omalizumab) brings new hope for severe asthma sufferers

The launch of a new drug to treat asthma has given new hope to people with severe asthma.

8 Nov 2005

Herceptin results beg questions on equal access to expensive drugs

The recent press coverage on the use of Herceptin (brand name for the drug trastuzumab) for treating breast cancer in its early stages shows that issues of equal access to costly but effective drugs must be confronted, says an editorial in the British Medical Journal.

7 Nov 2005

Unethical for doctors to withhold information from patients about new drugs

It is unethical and paternalistic for doctors to withhold information from patients about new drugs that are not yet publicly funded, say researchers in this week's British Medical Journal.

7 Nov 2005

FDA wants digital labels on all drugs - might solve the problem of very small print

The U.S. Food and Drug Administration is requesting drug manufacturers submit electronic versions of their drug labels in order that a database can be established for doctors and patients to search for recent warnings or any other changes.

3 Nov 2005

Withdrawn MS drug works for Crohn's sufferers

Researchers say that a multiple sclerosis drug that was withdrawn from the market for safety reasons, has shown some effectiveness against the painful bowel disorder Crohn's disease.

3 Nov 2005

Lung cancer drug approved for treating pancreatic cancer

Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.

3 Nov 2005

Drug company proposes FDA check all drug advertising prior to marketing

Drug company AstraZeneca has proposed that it should be a mandatory requirement for pharmaceutical companies to submit all direct-to-consumer advertising to the U.S. Food and Drug Administration for review prior to its use.

2 Nov 2005

'Morning-After Pill' still no decision by FDA

At the end of the two-month comment period on the "morning-after pill" Plan B, there is no indication when or how the Food and Drug Administration will proceed with the controversial application.

2 Nov 2005

Updated vaccine against cervical cancer provides longer sustainable response

Drug company GlaxoSmithKline says that it's updated vaccine against the human papillomavirus (HPV), has produced a stronger immune response, than the original formula of the vaccine.

2 Nov 2005

Bird flu drug combo could extend supplies

Doctors are saying that because of the scarcity of Tamiflu, presently being stockpiled by governments in the event of an influenza pandemic, supplies could be extended by giving it with another drug.

2 Nov 2005

Expanded use sought for colon cancer drug

Approval is being sought for a drug designed to treat colon cancer to be used also for the treatment of head and neck cancers.

1 Nov 2005

Roche seeking others to make Tamiflu bird flu drug

According to Swiss drug maker Roche, the maker of the sort-after bird flu drug Tamiflu, it is seeking for outside producers for its drug, because of the skyrocketing demand amid concerns about a possible bird flu pandemic.

31 Oct 2005

Big drug companies could lose out to generic competition

The battle between the big drug makers and their generic competition is intensifying, much to the benefit of consumers.

27 Oct 2005

Chiron initiates Phase I/II study of an investigational cell culture-derived influenza vaccine

Cell culture-derived influenza vaccine (commonly referred to as "flu cell culture" vaccine) represents the next generation of influenza vaccine, both for annual vaccine production and for long-term pandemic preparedness.

26 Oct 2005

FDA panel says approval for new depression drugs needs to be faster

According to a Food and Drug Administration (FDA) advisory panel, drug makers seeking U.S. approval of new drugs to treat major depression should not be required to first provide data on how well they work long-term.

26 Oct 2005

Way now clear for use of costly breast cancer drug throughout UK

Health managers in the UK have virtually been ordered to pay for the drug Herceptin for women with an aggressive form of breast cancer in its early stages.

26 Oct 2005

Counterfeit Tamiflu drug a very real threat

Health officials in the U.S. have expressed concern that with the current panic in many countries regarding bird flu, a counterfeit industry to produce the drug Tamiflu may already be in existence.

25 Oct 2005